DPT Meeting: FDA Opening Remarks AGENDA Opening Remarks Janet Woodcock, MD, U.S. Food and Drug Administration Billy Dunn, MD, U.S. Food and Drug Administration 2019 Duchenne Platform Trial Stakeholder Meeting, Conferences & Meetings Posted on October 11, 2019 FacebookTwitterLinkedinPin ItWhatsApp You may also like 10:23 Cumberland Pharmaceuticals Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Downstream Targets 7:11 Epirium Bio Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Restoring Dystrophin 11:46 NS Pharma Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Restoring Dystrophin 11:20 PTC Therapeutics (Ataluren) Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Reducing Inflammation 12:20 Catabasis Posted on July 6, 2020 Conferences & Meetings, In the Pipeline: Reducing Inflammation «1…1617181920…22»Page 18 of 22